Literature DB >> 27924520

Histopathological features of middle cerebral artery and superficial temporal artery from patients with moyamoya disease and enlightenments on clinical treatment.

Shou-Jia Sun1, Jian-Jian Zhang1,2, Zheng-Wei Li2, Zhong-Wei Xiong1,2, Xiao-Lin Wu1,2, Sheng Wang1, Kai Shu1, Jin-Cao Chen3,4.   

Abstract

The histopathological features of the middle cerebral artery (MCA) and superficial temporal artery (STA) from moyamoya disease (MMD) and their relationships with gender, age, angiography stage were explored. The causes and the clinical significance of vasculopathy of STA were also discussed. The clinical data and specimens of MCA and STA from 30 MMD patients were collected. Twelve samples of MCA and STA from non-MMD patients served as control group. Histopathological examination was then performed by measuring the thickness of intima and media, and statistical analysis was conducted. The MCA and STA specimens from MMD group had apparently thicker intima and thinner media than those from the control group. There was no significant pathological difference between the hemorrhage group and non-hemorrhage group, and between the males and females in MMD patients. Neither the age nor the digital subtraction angiography (DSA) stage was correlated with the thickness of intima in MCA and STA. MMD is a systemic vascular disease involving both intracranial and extracranial vessels. Preoperative external carotid arteriography, especially super-selective arteriography of the STA, benefits the selection of donor vessel.

Entities:  

Keywords:  middle cerebral artery; moyamoya disease; superficial temporal artery; vasculopathy

Mesh:

Year:  2016        PMID: 27924520     DOI: 10.1007/s11596-016-1677-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

1.  Superficial temporal artery-to-middle cerebral artery bypass.

Authors:  Fady T Charbel; Guido Meglio; Sepideh Amin-Hanjani
Journal:  Neurosurgery       Date:  2005-01       Impact factor: 4.654

Review 2.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

3.  Moyamoya disease associated with renovascular hypertension.

Authors:  J N Jansen; A J Donker; W J Luth; L M Smit
Journal:  Neuropediatrics       Date:  1990-02       Impact factor: 1.947

4.  Increase in prostaglandin E(2) production by interleukin-1beta in arterial smooth muscle cells derived from patients with moyamoya disease.

Authors:  M Yamamoto; M Aoyagi; N Fukai; Y Matsushima; K Yamamoto
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

Review 5.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

6.  Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease).

Authors:  Y Hosoda; E Ikeda; S Hirose
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

7.  Development of intimal thickening in superficial temporal arteries in patients with moyamoya disease.

Authors:  M Aoyagi; N Fukai; M Yamamoto; Y Matsushima; K Yamamoto
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

8.  An anatomic mathematical measurement to find an adequate recipient M4 branch for superficial temporal artery to middle cerebral artery bypass surgery.

Authors:  Paulo A S Kadri; Ali F Krisht; Gautam K Gandhi
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

9.  Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease.

Authors:  Osamu Togao; Futoshi Mihara; Takashi Yoshiura; Atsuo Tanaka; Yasuo Kuwabara; Takato Morioka; Toshio Matsushima; Tomio Sasaki; Hiroshi Honda
Journal:  AJR Am J Roentgenol       Date:  2004-07       Impact factor: 3.959

10.  Clinical and immunopathological features of Moyamoya disease.

Authors:  Runhua Lin; Zeyu Xie; Jianfa Zhang; Hongwu Xu; Hang Su; Xuerui Tan; Dongping Tian; Min Su
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more
  2 in total

Review 1.  Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.

Authors:  Yuting Luo; Zhixin Cao; Shaoqing Wu; Xunsha Sun
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

2.  Caveolin-1 Promoted Collateral Vessel Formation in Patients With Moyamoya Disease.

Authors:  Jinbing Zhao; Zhiqiang Yu; Yanping Zhang; Cheng Qiu; Guangxu Zhang; Lijiu Chen; Shengxue He; Jun Ma
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.